920 results match your criteria: "Fundacion Jimenez Diaz University Hospital[Affiliation]"
Expert Rev Hematol
February 2024
Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
Background: An accurate assessment of tumor viability after first-line treatment is critical for predicting treatment failure in peripheral T-cell lymphomas (PTCLs). F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) has been adopted as the preferred assessment method in clinical trials, but its impact in clinical practice should be examined. This study aims to determine the prognostic significance ofF-FDG-PET/CT for survival following first-line treatment in PTCL patients.
View Article and Find Full Text PDFArterioscler Thromb Vasc Biol
March 2024
Immunology Department, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain (M.M.-L., G.A.-L.).
Background: The metabolic alterations occurring within the arterial architecture during atherosclerosis development remain poorly understood, let alone those particular to each arterial tunica. We aimed first to identify, in a spatially resolved manner, the specific metabolic changes in plaque, media, adventitia, and cardiac tissue between control and atherosclerotic murine aortas. Second, we assessed their translatability to human tissue and plasma for cardiovascular risk estimation.
View Article and Find Full Text PDFTher Adv Med Oncol
January 2024
Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain.
Background And Objectives: Dimensional response is an unmet need in second lines of advanced soft tissue sarcomas (STS). Indeed, the three approved drugs, pazopanib, trabectedin, and eribulin, achieved an overall response rate (ORR) of less than 10%. This fact potentially hinders the options for fast symptomatic relief or surgical rescue.
View Article and Find Full Text PDFColorectal Dis
March 2024
Department of Surgery, Fundación Jimenez Diaz University Hospital, Madrid, Spain.
J Neuroophthalmol
December 2024
Washington University in St. Louis School of Medicine (SS, GVS, LMH), St. Louis, Missouri; Indiana University School of Medicine (VJM, RSM), Indianapolis, Indiana; John A. Moran Eye Center (A. Shakoor, AV), University of Utah, Salt Lake City, Utah; Sue Anschutz-Rogers Eye Center (AGP), University of Colorado School of Medicine, Denver, Colorado; Wilmer Eye Institute (JET), Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine (DAG), Chicago, Illinois; CT Uveitis Foundation (PAG), West Hartford, Connecticut Manhattan Eye, Ear and Throat Hospital (NG), New York, New York; Hospital Universario Austral (A. Schlaen), Austral University, Buenos Aires, Argentina; Tennessee Retina (AT), Nashville, Tennessee; Rush University/Illinois Retina Associates (PTM, VR), Chicago, Illinois; Cole Eye Institute (PL), Cleveland Clinic, Cleveland, Ohio; University of Puerto Rico (ALO), San Juan, Puerto Rico; Associated Vitreoretinal and Uveitis Consultants (RSM), Carmel, Indiana; SightMD (GC), Yonkers, New York; Fundacion Jimenez Diaz University Hospital (EC), Madrid, Spain; and Mayo Clinic (WMS), Rochester, Minnesota.
Background: Optic disc edema is a feature of many ophthalmic and neurologic conditions. It remains an underappreciated feature of birdshot chorioretinitis (BSCR), leading to delay in diagnosis and treatment. The purpose of our study was to identify clinical features that are concomitant with optic disc edema and suggest a diagnosis of BSCR.
View Article and Find Full Text PDFEur J Cancer
March 2024
Department of Oncology, OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address:
Biliary tract cancers (BTCs) encompass a heterogeneous group of rare tumors, including intrahepatic cholangiocarcinoma (iCCA), extrahepatic cholangiocarcinoma (eCCA), gallbladder cancer (GBC) and ampullary cancer (AC). The present first-line palliative treatment regimen comprises gemcitabine and cisplatin in combination with immunotherapy based on two randomized controlled studies. Despite the thorough investigation of these palliative treatments, long-term survival remains low.
View Article and Find Full Text PDFAccount Res
January 2024
Center for Evidence-Based Medicine and Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
Research integrity is the cornerstone for a reliable and trustworthy science. Research misconduct is classically defined as fabrication, falsification, or plagiarism. To be considered as such, the action must have been committed with the intent to mislead or deceive.
View Article and Find Full Text PDFBiomolecules
January 2024
Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.
(1) Background: Eosinophilia has traditionally been linked to eosinophilic asthma, for which it is the gold-standard prognostic biomarker. However, the association between eosinophilia and the presence of other diseases and comorbidities is yet unclear. (2) Methods: For this retrospective study, we reviewed the electronic medical records of 49,909 subjects with blood eosinophilia to gather data on the presence of asthma, COPD, sleep apnea, tuberculosis, dyslipidemia, hypertension, and other cardiovascular diseases and severe CRSwNP among these subjects.
View Article and Find Full Text PDFJ Clin Oncol
March 2024
Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Purpose: A randomized trial was conducted to compare neoadjuvant standard (S) anthracycline + ifosfamide (AI) regimen with histology-tailored (HT) regimen in selected localized high-risk soft tissue sarcoma (STS). The results of the trial demonstrated the superiority of S in all STS histologies except for high-grade myxoid liposarcoma (HG-MLPS) where S and HT appeared to be equivalent. To further evaluate the noninferiority of HT compared with S, the HG-MLPS cohort was expanded.
View Article and Find Full Text PDFRheumatology (Oxford)
July 2024
Unit for Autoimmune Diseases, Rheumatology Department, Fundación Jiménez Díaz University Hospital and Health Research Institute (IIS-FJD), Madrid, Spain.
Future Oncol
June 2024
Department of Hepatobiliary & Pancreatic Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Mouse double minute 2 homolog (MDM2) is a key negative regulator of the tumor suppressor p53. Blocking the MDM2-p53 interaction, and restoring p53 function, is therefore a potential therapeutic strategy in -amplified, wild-type tumors. is amplified in several tumor types, including biliary tract cancer (BTC), pancreatic ductal adenocarcinoma (PDAC), lung adenocarcinoma and bladder cancer, all of which have limited treatment options and poor patient outcomes.
View Article and Find Full Text PDFCancer Med
February 2024
Department of Pathology, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Objective: This study aimed to describe the performance of a next-generation sequencing (NGS) panel for the detection of precise genomic alterations in cancer in Spanish clinical practice. The impact of tumor characteristics was evaluated on informative NGS and actionable mutation rates.
Materials And Methods: A cross-sectional study was conducted at the Fundación Jiménez Díaz University Hospital (May 2021-March 2022) where molecular diagnostic of 537 Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples of diverse solid tumors (lung, colorectal, melanoma, gastrointestinal stromal, among others) was performed using AVENIO Tumor Tissue Targeted Kit.
JACC CardioOncol
December 2023
Cardiology Department, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
Despite improvements in cancer survival, cancer therapy-related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning field of cardio-oncology, which aims to advance the cardiovascular health of cancer patients and survivors, through actionable and translatable science. In these Global Cardio-Oncology Symposium 2023 scientific symposium proceedings, we present a focused review on the mechanisms that contribute to common cardiovascular toxicities discussed at this meeting, the ongoing international collaborative efforts to improve patient outcomes, and the bidirectional challenges of translating basic research to clinical care.
View Article and Find Full Text PDFInt J Mol Sci
December 2023
New Therapy Laboratory, Health Research Institute Fundación Jiménez Díaz, 28033 Madrid, Spain.
Int J Mol Sci
December 2023
Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD, UAM)-CIBERONC, 28040 Madrid, Spain.
The combination of trastuzumab and pertuzumab as first-line therapy in patients with HER2-positive breast cancer has shown significant clinical benefits compared to trastuzumab alone. However, despite initial therapeutic success, most patients eventually progress, and tumors develop acquired resistance and invariably relapse. Therefore, there is an urgent need to improve our understanding of the mechanisms governing resistance in order to develop targeted therapeutic strategies with improved efficacy.
View Article and Find Full Text PDFJ Exp Clin Cancer Res
January 2024
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Background: The variability in responses to neoadjuvant treatment with anti-HER2 antibodies prompts to personalized clinical management and the development of innovative treatment strategies. Tumor-infiltrating Natural Killer (TI-NK) cells can predict the efficacy of HER2-targeted antibodies independently from clinicopathological factors in primary HER2-positive breast cancer patients. Understanding the mechanism/s underlying this association would contribute to optimizing patient stratification and provide the rationale for combinatorial approaches with immunotherapy.
View Article and Find Full Text PDFUrol Int
April 2024
Department of Pediatric Surgery, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Introduction: The management of acute scrotal swelling can be challenging in neonatal age, with scrotal abscess being great mimickers of testicular torsion.
Case Presentation: We report a 12-day-old previously healthy male infant who presented with 72 h of increasing right-sided scrotal swelling, without fever or irritable behavior. The left testicle was palpable, but the right side was too swollen to palpate a testicle, with absent cremasteric reflex.
Ther Adv Psychopharmacol
December 2023
West London National Health System (NHS) Trust, London, UK.
Background: Paliperidone palmitate 6-monthly (PP6M) is the first long-acting antipsychotic injectable (LAI) to allow for only two medication administrations per year, though there is presently limited insight into its effectiveness and potential added value in real clinical practice conditions.
Objectives: To present our ongoing study and draw its preliminary data on patient characteristics initiating PP6M and adherence during the first year of treatment.
Methods: The paliperidone 2 per year (P2Y) study is a 4-year, multicentre, prospective mirror-image pragmatic study taking place at over 20 different sites in Europe.
Front Immunol
December 2023
HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
The immune system of people living with HIV (PLWH) is persistently exposed to antigens leading to systemic inflammation despite combination antiretroviral treatment (cART). This inflammatory milieu promotes T-cell activation and exhaustion. Furthermore, it produces diminished effector functions including loss of cytokine production, cytotoxicity, and proliferation, leading to disease progression.
View Article and Find Full Text PDFTransl Pediatr
November 2023
Department of Pediatric Surgery, La Paz Children's University Hospital, Madrid, Spain.
Background: Neutrophil-to-lymphocyte ratio (NLR) has been recently postulated as an inflammatory biomarker for the diagnosis of vesicoureteral reflux (VUR). The aim of this study is to determine the role of NLR as a predictor of evolution of primary VUR in patients with associated acute pyelonephritis (APN).
Methods: A retrospective observational cohort study was performed in patients with APN episodes with associated primary VUR diagnosed between 2013-2020.
Front Immunol
December 2023
Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz Universidad Autonoma de Madrid (UAM), Madrid, Spain.
[This corrects the article DOI: 10.3389/fimmu.2023.
View Article and Find Full Text PDFCardiovasc Diabetol
December 2023
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Calle Melchor Fernández Almagro, 3, Madrid, 28029, Spain.
Background: Elevated glycated hemoglobin (HbA1c) is associated with a higher burden of subclinical atherosclerosis (SA). However, the association with SA of earlier insulin resistance markers is poorly understood. The study assessed the association between the homeostatic model assessment of insulin resistance index (HOMA-IR) and SA in addition to the effect of cardiovascular risk factors (CVRFs) in individuals with normal HbA1c.
View Article and Find Full Text PDFNeurobiol Dis
January 2024
Division of Psychology, School of Humanities, Social Sciences and Law, University of Dundee, Dundee, UK.
Electroencephalography (EEG) has shown potential for identifying early-stage biomarkers of neurocognitive dysfunction associated with dementia due to Alzheimer's disease (AD). A large body of evidence shows that, compared to healthy controls (HC), AD is associated with power increases in lower EEG frequencies (delta and theta) and decreases in higher frequencies (alpha and beta), together with slowing of the peak alpha frequency. However, the pathophysiological processes underlying these changes remain unclear.
View Article and Find Full Text PDFJ Neuroendocrinol
January 2024
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.
J Virol
December 2023
Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Upon the emergence of SARS-CoV-2 in the human population, it was conjectured that for this coronavirus the dynamic intra-host heterogeneity typical of RNA viruses would be toned down. Nothing of this sort is observed. Here we review the main observations on the complexity and diverse composition of SARS-CoV-2 mutant spectra sampled from infected patients, within the framework of quasispecies dynamics.
View Article and Find Full Text PDF